1. Home
  2. GNPX vs ASTC Comparison

GNPX vs ASTC Comparison

Compare GNPX & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$1.76

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$4.54

Market Cap

6.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
ASTC
Founded
2009
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
6.1M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
GNPX
ASTC
Price
$1.76
$4.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
278.5K
4.8M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2600.00
EPS
N/A
0.25
Revenue
N/A
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$19.24
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$1.92
52 Week High
$12.97
$8.01

Technical Indicators

Market Signals
Indicator
GNPX
ASTC
Relative Strength Index (RSI) 39.18 78.05
Support Level $0.18 $3.40
Resistance Level $2.12 $5.37
Average True Range (ATR) 0.10 0.45
MACD -0.01 0.26
Stochastic Oscillator 16.15 58.38

Price Performance

Historical Comparison
GNPX
ASTC

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Share on Social Networks: